Seed and Early-Stage Biotech & Life-Science Investors: 154 VC Firms, Corporate VCs, Venture Studios and Accelerators in 24 Countries - Each With the Firm's Own Statement of Its Stage and Sector Focus (Partial List)
154 investment organisations that say on their own website that they invest in, found or accelerate seed, early-stage or Series A biotech, therapeutics or life-science companies: venture capital firms, corporate venture arms, venture studios / company creators, accelerators and university-linked or public seed investors. Head offices: United States 56, Europe 63, Asia-Pacific and Middle East 26, Canada 9. One row per organisation with head-office country and city, firm type, the stage and sector focus in the words of the firm's own statement, the page and the exact wording, plus up to 3 portfolio companies named on the firm's own portfolio page (40 rows) and the latest Form D found on SEC EDGAR for one of its funds (62 rows). Organisations only: no partner names, no contact details. Not a complete list of such investors; it is the firms whose statements we could confirm on their own sites, as of 2026-10-12.
Data Preview
* The first 5 rows of the full list (real data).| firm_name | hq_country | hq_city | firm_type | stated_stage_focus | stated_therapeutic_or_sector_focus |
|---|---|---|---|---|---|
| 4BIO Capital | United Kingdom | London | Venture capital firm | early-stage | therapeutics / drug development; health / medical (general) |
| 5AM Ventures | United States | San Francisco | Venture capital firm | early-stage | life sciences |
| Abingworth | United Kingdom | London | Venture capital firm | early-stage | life sciences |
| adMare BioInnovations | Canada | Vancouver | Venture studio / venture creation firm | early-stage; company creation / incubation | therapeutics / drug development |
| Advent Life Sciences | United Kingdom | London | Venture capital firm | seed; Series A | therapeutics / drug development |
Showing 6 of 12 columns. All columns are listed below.
Full list: 154 rows · CSV · last verified Oct 12, 2026
* One-time payment via Stripe · Organization info only · No change-of-mind refunds (digital product)
Where the source data is published
Everything in this list is published free of charge by the firms themselves (their own websites) and by the U.S. SEC (EDGAR Form D filings, free). ReqoData's work is finding and checking the statements across 400 candidate firm websites, rejecting the ones that do not hold up, labelling stage and sector from the wording, matching Form D fund filings by hand and picking portfolio names from the firms' own portfolio pages.
Read the full noteAbout this list
- Rows
- 154
- Columns
- 12
- Format
- CSV (UTF-8, opens in Excel)
- Last verified
- Oct 12, 2026
Source data as of
Firm web pages read and every quote re-checked live on 2026-10-12; SEC EDGAR Form D data as of 2026-10-12
Last verified is the date we fetched the source data and confirmed it was the latest version the publishers had released.
What this list adds to the free source data
- Every row is backed by the firm's own public statement: the URL of a page on the firm's website and the exact sentence(s) in which it describes the stages and sectors it invests in. All 154 quotes were re-fetched and found on the live page on 2026-10-12.
- stated_stage_focus and stated_therapeutic_or_sector_focus are standard labels derived only from the words in the quote (for example seed, Series A, early-stage, company creation / incubation; biotech, therapeutics, medtech, diagnostics), so firms can be filtered in a spreadsheet; 46 quotes name seed / pre-seed or Series A explicitly and 41 describe company creation, incubation or an accelerator.
- Where the quote also names sectors outside life sciences (generalist or multi-sector investors, 32 rows), the sector column says so ('also non-life-science sectors'), so specialist and generalist investors can be told apart.
- latest_fund_form_d: for 62 firms, the most recent Form D we matched by hand to one of the firm's fund entities on SEC EDGAR (fund name as filed, filing date, total offering amount and the filing link), as public evidence that the fund exists.
- example_portfolio_companies: for 40 firms, up to 3 life-science company names that appear on the firm's own portfolio page (each name re-checked on that page on 2026-10-12).
- Each candidate statement was read by hand: sentences about individuals (team biographies), about other firms, portfolio-company descriptions that do not show the firm's own stage, and clinical / growth-only statements were not used (reasons in meta.excluded).
Limitations and what's not included
- Not a complete list of seed / early-stage life-science investors. Candidate firms came from ReqoData's own research (400 websites checked); firms outside that set, firms whose sites need JavaScript to show text, block automated access in robots.txt, or did not answer, and firms whose pages did not contain a sentence stating both an early-stage and a life-science focus are not included. Crunchbase, PitchBook and CB Insights were not used (their terms prohibit it).
- The stage label is what the quote says, not a measure of what the firm actually does most. Many firms also invest at later stages: 35 rows include 'Series B / later' because the quote itself says so (e.g. 'from seed to growth', 'from early-stage to revenue-generating'). A firm's focus can change after the page was written; most pages are not dated.
- A few quotes describe a fund or programme of the organisation rather than the whole organisation (e.g. a seed fund, a venture lab or accelerator programme run by a charity, university or corporate group), and a few rely on a headline on the firm's own site (e.g. 'X launches with $75 million from <firm>' or '<firm> led the Series A'). Two quotes are in the language of the page (German: MIG Capital; Dutch: UNIIQ).
- 37 quotes join two sentences from the same page with ' [...] ' (each part is verbatim and was checked separately).
- hq_country is ReqoData research (the firm's own site, its Form D address, or general knowledge of the firm). hq_city is filled only where the firm's own site states the city (145 rows) or, failing that, where it is the business address in the matched Form D (2 rows); it is blank otherwise. Some firms list several offices; the city shown is one stated office, not necessarily the legal seat.
- latest_fund_form_d is the most recent Form D found by EDGAR company-name lookup for fund entities whose names match the firm and which we matched by hand; it may not be the firm's newest fund (newer funds may use other names, may not have filed in the U.S., or may file later). Blank means none was matched, not that the firm has no fund. Total offering amount is as filed ('indefinite' where the filer says so) and is not the amount raised.
- example_portfolio_companies lists names found on the firm's portfolio page on the build date; it does not say when or at what stage the firm invested, and some may be exited (as the page shows). Blank for firms whose portfolio page needs JavaScript or has no extractable names.
- firm_type is ReqoData's label (venture capital firm, corporate venture capital, venture studio / company creator, accelerator, state or university-linked investor, etc.); it is not an official category.
- Organisation data only: no personal names, e-mail addresses or phone numbers. Statements that named individuals were not used, and individual angel investors are not included.
Where the source data is published
Everything in this list is published free of charge by the firms themselves (their own websites) and by the U.S. SEC (EDGAR Form D filings, free). ReqoData's work is finding and checking the statements across 400 candidate firm websites, rejecting the ones that do not hold up, labelling stage and sector from the wording, matching Form D fund filings by hand and picking portfolio names from the firms' own portfolio pages.
Organization info only. The list contains no personal contact details of individuals.
Columns in the CSV (12)
| Column | Description |
|---|---|
| firm_name | Organisation name as used on its own site (a former name or the relevant arm in parentheses where useful). |
| hq_country | Country of the head office (ReqoData research; see limitations). |
| hq_city | City as stated on the firm's own site (or, where the site states none, the business address in the matched Form D); blank if neither states it. Several offices separated by '; '. |
| firm_type | ReqoData label: venture capital firm, corporate venture capital, venture studio / venture creation firm, accelerator / incubator, life science investment company, state or university-linked investor, venture philanthropy fund, etc. |
| stated_stage_focus | Stage labels derived only from the words of evidence_quote: pre-seed, seed, Series A, early-stage, preclinical / discovery stage, start-ups, company creation / incubation, accelerator, first institutional round, Series B / later. Several separated by '; '. |
| stated_therapeutic_or_sector_focus | Sector labels derived only from the words of evidence_quote (biotech, life sciences, therapeutics / drug development, medtech / medical devices, diagnostics, digital health / healthtech, healthcare, oncology, neuroscience, rare diseases, longevity / ageing, ...). 'also non-life-science sectors' means the quote also names sectors outside life sciences. |
| example_portfolio_companies | Up to 3 life-science company names found on the firm's own portfolio page (re-checked on the build date); blank if none was taken. Separated by '; '. |
| latest_fund_form_d | Most recent Form D (or D/A) found on SEC EDGAR for a fund entity matched to the firm: entity name as filed - Form - filing date (total offering amount as filed) - filing index URL. Blank if none matched. |
| website | The firm's home page. |
| source_url | Page on the firm's own website carrying evidence_quote. |
| evidence_quote | The firm's own wording about the stages and sectors it invests in (verbatim; whitespace and quote marks normalised; two sentences from the same page joined with ' [...] '). |
| last_verified | Date the quote was last found on the live source_url. |
Sources and licenses
- The firms' own websites (one page per row, linked in source_url; portfolio pages for example_portfolio_companies)ToS judgement: usable. Each firm's public description of itself; we quote one or two short factual sentences per row with a link, and list up to 3 company names from its public portfolio page. robots.txt was checked for every origin before fetching and disallowed pages were not fetched (401/403 on robots.txt treated as disallow-all). No login, no JavaScript execution, no browser, no bot-challenge bypass; plain HTTP GET with a declared user agent.
- U.S. SEC EDGAR - Form D filings of the firms' funds (data.sec.gov submissions and the filing's primary_doc.xml; EDGAR company-name lookup used only to find the filer)ToS judgement: usable. U.S. government public records. Accessed under the SEC's 'Accessing EDGAR Data' fair-access policy (declared user agent with a contact address, at most 4 requests per second, below the 10/s limit).
Last verified: Oct 12, 2026
Frequently Asked Questions
Q.Where does the data come from?
Mainly from the official registers and other public data listed on this page under “Sources and licenses”. For some lists, ReqoData added columns (such as website URLs) after checking each organization's own website; those sources are listed there too. Organization info only — no personal contact details.
Q.Is the full list available now?
Yes. After payment you get the CSV (154 rows, last verified Oct 12, 2026) on a download page right away.
Q.What does it cost?
$149, a one-time card payment through Stripe. There is no subscription. As a digital product, it can't be returned for change of mind; if the file has a material error, report it from the download page and we'll provide a corrected file or a refund.
Q.Is the list updated after purchase?
No. The CSV reflects the sources as of Firm web pages read and every quote re-checked live on 2026-10-12; SEC EDGAR Form D data as of 2026-10-12; on Oct 12, 2026 (last verified) we confirmed these were the latest versions published. It isn't updated automatically, and there is no API. If you download it again later, you get the version of this list we provide at that time.
Q.What format is it delivered in?
CSV (opens in Excel or Google Sheets). There is no API.